Although the mechanism by which PR1P targets the injured myocardium is not clear, this novel property of targeting VEGF signaling where needed could potentially be used to target oxygen-deprived but not yet infarcted regions in the heart during unstable angina or for peripheral vascular occlusive disease where inflammation is also noted [46,47]. The gene discussed is VEGFA; the disease is angina pectoris.